April 14-16, 2026 – Rio de Janeiro, BRAZIL – Trasis exhibiting

Event details

Event: TAT 13, 13th International Symposium of Targeted ALPHA THERAPY
Dates: April 14-16, 2026
Location: Windsor Barra Convention Center – Rio de Janeiro, BRAZIL
Booth: 5

We look forward to connecting with you.

Join Trasis (booth 5) at TAT 13 2026 to discuss practical solutions that help radiopharmacy teams streamline operations, from synthesis to quality control.

Our colleagues Manu & Charly will be on site to discuss your projects and operational challenges.

Schedule a meeting

Solutions in focus

MiniAllinOne: radiochemistry synthesizer for routine production

Compact, fully automated radiotracer synthesizer for theranostic workflows. One platform for 18F, 68Ga, 177Lu and more, with ready-to-use GMP cassettes and RFID checks.

Contact our experts

QC1 automated radiopharmaceutical quality control system

QC1 automated radiopharmaceutical quality control

Designed to streamline your QC workflows, QC1 is a fully integrated, self-shielded system that brings safety, efficiency, and performance to a new level, and is compatible with European and US pharmacopeia.

With QC1, cut down on repetitive tasks and unlock your team’s full potential.

Contact our experts

SteriNow, for in-house and automated sterility testing

Sterinow® automates sterility test preparation using membrane filtration, directly on site, enhancing compliance, reducing operator exposure, and streamlining a critical quality control step in radiopharmaceutical production.

Sterinow® is a cassette-based solution that automates the preparation of sterility test samples using membrane filtration, with a process developed on Trasis’ synthesizer miniAllinOne, to simplify this critical QC step while ensuring regulatory compliance and improving operator safety and cost efficiency.

Contact our experts

SteriNow automated sterility test preparation

CDMO services

Trasis offers comprehensive services, from the chemical synthesis of small molecules and peptides to the production of ready-to-use drug solutions.

Scalable API & precursor synthesis (from R&D to commercial production)
Raw material sourcing & cGMP assessment
Polymorph screening, impurity profiling & stability studies
Process analytics & regulatory (CMC) support

Contact our experts

Plan a meeting at TAT 13

Want dedicated time with an expert during the event? Send us your topic and preferred time window – we will confirm availability.

Schedule a meeting

Meet Trasis at TAT 13 2026